D. Western Therapeutics Institute Inc (fra:6DW) Share Price

Company Profile

Business description
D. Western Therapeutics Institute Inc is engaged in the research and development of pharmaceutical drugs in Japan. Its products include ophthalmic solution and agents for antiplatelet and anti-glaucoma.
Contact
7th Floor, 18 KT Bulding
1-18-11, Nishiki, Naka-ku
Aichi
Nagoyashi460-0003
JPN
T: +81 52218785
http://www.dwti.co.jp
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
21

Recommended

Investors cheered an increased dividend but still heavily dependent on iron ore.

Jon Mills, CFA | 18 February 2026

Our view of the shares after investors cheer results.

Jon Mills, CFA | 17 February 2026

We maintain our fair value as talks continue with Paramount,

Matthew Dolgin, CFA | 17 February 2026

Index	Last price	Change	% Change
All Ordinaries	9,238.70	21.50	0.23%
CAC 40	8,434.05	72.59	0.87%
DAX 40	25,284.29	285.89	1.14%
Dow JONES (US)	49,811.22	278.03	0.56%
FTSE 100	10,687.45	131.28	1.24%
HKSE	26,705.94	138.82	0.52%
NASDAQ	22,869.10	290.71	1.29%
Nikkei 225	57,143.84	577.35	1.02%
NZX 50 Index	13,247.02	215.40	1.65%
S&P 500	6,901.10	57.88	0.85%
S&P/ASX 200	9,007.00	12.80	0.14%
SSE Composite Index	4,082.07	51.95	-1.26%